Indicated for: hypertension
Route of administration: oral
Substance: telmisartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)
ATC: C09DA07 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)
Dose adjustment may be needed in kidney disease.
Do not use this medicine during pregnancy.
Avoid excessive exposure to sunlight or UV radiation.
May lower blood pressure and increase the risk of falls.
This medicine may have important interactions with other medicines.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
This combination of telmisartan and hydrochlorothiazide is used for the treatment of hypertension in patients not adequately controlled with a single medication. Telmisartan blocks angiotensin II receptors, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or nausea. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, electrolyte imbalances, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.